COMMUNIQUÉS West-GlobeNewswire

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0475 Per Share
14/12/2018
MISSION VIEJO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license
14/12/2018
Pratteln, Switzerland, December 14, 2018 - Santhera Pharmaceuticals Holding AG (SIX: SANN) has completed its ordinary capital increase with the placement of 3,133,334 new shares by way of an accelerated bookbuilding and [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
14/12/2018
Company announcement – No. 31 / 2018 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, December 14, 2018 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a [...]
Santhera Provides Update on the Share Placement
14/12/2018
Pratteln, Switzerland, December 14, 2018 - Santhera Pharmaceuticals Holding AG (SIX: SANN) provides an update on the accelerated bookbuilding. On December 12, 2018, Santhera Pharmaceuticals Holding AG announced the [...]
FIT Biotech Oy: FIT Biotech's financial calendar and Annual General Meeting in 2019
14/12/2018
FIT Biotech Oy Company release 14.12.2018 at 09:00 AM EET FIT Biotech's financial calendar and Annual General Meeting in 2019 During the year 2019, FIT Biotech Oy will publish the Financial Statement release 2018 and [...]
Rule 2.9 Announcement
14/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 December 2018 [...]
Sensorion Announces Positive Topline Results From Seliforant Phase 2a Study
14/12/2018
Results confirmed Seliforant does not affect vigilance, cognitive performance during a motion stimulus MONTPELLIER, France, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN) , a pioneering clinical- [...]
Dentsply Sirona Declares Quarterly Cash Dividend
14/12/2018
YORK, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0.0875 [...]
Canada House Wellness Group Reports Second Quarter Fiscal Year 2019 Results
14/12/2018
54% Increase in Revenue compared to the same Period in the Prior Year NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness [...]
Genmab Announces Submission of Supplemental New Drug Application for Daratumumab in Front Line Multiple Myeloma in Japan
14/12/2018
Company Announcement Supplemental new drug application submitted in Japan for daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma [...]
Extendicare Announces December 2018 Dividend of C$0.04 per Share
14/12/2018
MARKHAM, Ontario, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Teligent, Inc. Executes $120 Million Financing Agreement
14/12/2018
BUENA, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that on December 13, 2018 the Company entered into a definitive first lien revolving credit [...]
PotNetwork Holdings, Inc. Withdraws Form 10
13/12/2018
FORT LAUDERDALE, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that the Company filed a request with the Securities and Exchange Commission ("SEC") [...]
Axovant Sciences Announces Public Offering of Common Shares
13/12/2018
BASEL, Switzerland, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (Nasdaq: AXON) ("Axovant") today announced that it has commenced an underwritten public offering of its common shares. All of the common shares are [...]
Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®
13/12/2018
Expects to Announce Results of Meeting After Receipt of Final Minutes from FDA PRINCETON, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced [...]
Ziopharm Oncology Promotes Dr. David Mauney to President
13/12/2018
BOSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that David Mauney, M.D., has been promoted to President effective immediately. Dr. Mauney, who joined Ziopharm in 2017 as [...]
Conformis Announces Strategic Actions to Reach Profitability and Reduce Debt
13/12/2018
Conformis Provides 2019 Cost & Debt Reduction Initiatives Optimize sales, marketing and administrative expense to take advantage of recently achieved gross margin & operational efficiencies Sharpen focus on new [...]
OrthoPediatrics Corp. Announces Full-Scale U.S. Launch of Small Stature Scoliosis System
13/12/2018
WARSAW, Ind., Dec. 13, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the full-scale U.S. launch of its 26 [...]
National Institute on Drug Abuse Presents Data on Trevena’s TRV734 at the 57th Annual Meeting of the American College of Neuropsychopharmacology
13/12/2018
CHESTERBROOK, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in [...]

Pages